RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)

CUSIP: 75629V104

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Class A Common Stock
Shares outstanding
514,715,255
Total 13F shares
212,714,397
Share change
+6,232,465
Total reported value
$2,120,552,518
Put/Call ratio
193%
Price per share
$9.97
Number of holders
242
Value change
+$62,304,334
Number of buys
152
Number of sells
68

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q1 2024

As of 31 Mar 2024, RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by 242 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 212,714,397 shares. The largest 10 holders included ARK Investment Management LLC, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, Mubadala Investment Co PJSC, BlackRock Inc., Kinnevik AB (publ), Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., STATE STREET CORP, and FMR LLC. This page lists 243 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.